Evidence map›Paper›PMID 42736327›Full record

ArticleLeukemia2026

SRSF2 P95H induces monocytic priming of human hematopoietic stem and progenitor cells.

Johannes Foßelteder, Gabriel Pabst, Andrea Raicht, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Daniel Martinez-Krams, Asiri Ediriwickrema, Katarina Vizar-Cisarova, Peter Schlenke and 5 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Johannes Foßelteder *Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-0241-6822
Gabriel Pabst *Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-1346-6398
Andrea RaichtDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria.
Tommaso SconocchiaDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-8735-7958
Angelika SchlacherDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Lisa AuingerDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.
Daniel Martinez-KramsDepartment of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-9731-605X
Asiri EdiriwickremaDepartment of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-6480-8290
Katarina Vizar-CisarovaDepartment of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-2711-0480
Peter SchlenkeDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Graz, Graz, Austria.
Annkristin HeineDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-5298-9880
Heinz SillDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-0993-4371
Armin ZebischDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-4861-7021
Ravindra MajetiDepartment of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-5814-0984
Andreas ReinischDepartment of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria. a.reinisch@medunigraz.at.ORCID http://orcid.org/0000-0001-9333-7689

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P36672Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) PAT1753824
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42736327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.